|
|
 |
|
Viewing report
|
|
|
|
Vivus, Inc.
Datamonitor, Sep 2008, Pages: 27
The Vivus, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Vivus is a specialty pharmaceutical company focused on research, development and commercialization of products in the areas of sexual health, obesity and diabetes. The company markets Muse and Actis used for the treatment of erectile dysfunction. Vivus is headquartered in Mountain View, California and employs more than 110 people. The company recorded revenues of $54.7 million during the financial year (FY) ended December 2007, as compared to $17.2 million in FY2006. The increase in revenues was primarily due to the recognition of $20.9 million in deferred license revenue earned from the sale of Evamist to K-V Pharmaceutical Company (K-V). The operating loss of the company was $1.5 million during FY2007, compared to an operating loss of $22.6 million in FY2006. The net loss was $2.4 million in FY2007, as against a net loss of $216 million in FY2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Idenix Pharmaceuticals, Inc.
VIVUS, Inc. (VVUS) - Financial and Strategic Analysis Review
Auxilium Pharmaceuticals, Inc. - SWOT Analysis
Enzon Pharmaceuticals, Inc. - SWOT Analysis
MEDIQ N.V. - SWOT Analysis
ISTA Pharmaceuticals, Inc. - SWOT Analysis
Progenics Pharmaceuticals, Inc. - SWOT Analysis
Isis Pharmaceuticals, Inc. - SWOT Analysis
Vertex Pharmaceuticals, Inc. - SWOT Analysis
Barrier Therapeutics, Inc.
Vertex Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. - SWOT Analysis
|
|
|
|
